{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis%2C+NOS&page=3", "query": { "condition": "Rheumatoid Arthritis, NOS", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1118, "total_pages": 112, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis%2C+NOS&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Rheumatoid+Arthritis%2C+NOS&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-02T11:12:46.466Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00248105", "title": "Improving Motivation for Physical Activity in Arthritis Clinical Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis, Knee", "Rheumatoid Arthritis" ], "interventions": [ { "name": "Lifestyle Physical Activity Management", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 889, "start_date": "2005-09", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2013-11-04", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 2, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00248105" }, { "nct_id": "NCT01721057", "title": "A Study in Moderate to Severe Rheumatoid Arthritis Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Baricitinib", "type": "DRUG" }, { "name": "cDMARD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 684, "start_date": "2012-12", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2019-09-18", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 48, "location_summary": "Glendale, Arizona • Peoria, Arizona • Phoenix, Arizona + 45 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01721057" }, { "nct_id": "NCT02747277", "title": "Analysis of B Cells From Autoimmune Individuals", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lupus Erythematosus", "Rheumatoid Arthritis", "Type 1 Diabetes" ], "interventions": [], "intervention_types": [], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 46, "start_date": "2016-05", "completion_date": "2022-01", "has_results": false, "last_update_posted_date": "2023-12-04", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 1, "location_summary": "Aurora, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02747277" }, { "nct_id": "NCT01626573", "title": "A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Itacitinib", "type": "DRUG" }, { "name": "Itacitinib Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Incyte Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 106, "start_date": "2012-03", "completion_date": "2013-10", "has_results": false, "last_update_posted_date": "2019-03-12", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 17, "location_summary": "Palm Desert, California • Pasadena, California • Lake Mary, Florida + 14 more", "locations": [ { "city": "Palm Desert", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Lake Mary", "state": "Florida" }, { "city": "Ocala", "state": "Florida" }, { "city": "Palm Harbor", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01626573" }, { "nct_id": "NCT04817969", "title": "Persona Ti-Nidium Post-Market Clinical Follow-up", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Knee Pain Chronic", "Osteoarthritis", "Rheumatoid Arthritis", "Traumatic Arthritis", "Polyarthritis", "Varus Deformity", "Valgus Deformity", "Flexion Deformity of the Knee", "Avascular Necrosis", "Patellofemoral Osteoarthritis" ], "interventions": [ { "name": "Zimmer Biomet Persona Ti-Nidium Total Knee System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2021-06-01", "completion_date": "2034-05", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 7, "location_summary": "Parker, Colorado • Hyattsville, Maryland • Jackson, Mississippi + 4 more", "locations": [ { "city": "Parker", "state": "Colorado" }, { "city": "Hyattsville", "state": "Maryland" }, { "city": "Jackson", "state": "Mississippi" }, { "city": "Albuquerque", "state": "New Mexico" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04817969" }, { "nct_id": "NCT02799472", "title": "Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "GSK3196165", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "MTX", "type": "DRUG" }, { "name": "Folic (or folinic) acid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2016-06-15", "completion_date": "2017-10-30", "has_results": true, "last_update_posted_date": "2021-01-11", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 8, "location_summary": "El Cajon, California • Fort Lauderdale, Florida • Miami, Florida + 5 more", "locations": [ { "city": "El Cajon", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Pinellas Park", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799472" }, { "nct_id": "NCT01369589", "title": "An Evaluation of the Impact of a Single Dose of P-552 on Oral Mucosal Wetness", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Xerostomia", "Sjogren's Syndrome" ], "interventions": [ { "name": "P-552", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Parion Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2010-11", "completion_date": "2011-04", "has_results": false, "last_update_posted_date": "2019-04-23", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01369589" }, { "nct_id": "NCT01962415", "title": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Immunodeficiency (PID)", "Congenital Bone Marrow Failure Syndromes", "Inherited Metabolic Disorders (IMD)", "Hereditary Anemias", "Inflammatory Conditions", "Systemic Juvenile Idiopathic Arthritis (sJIA)", "Juvenile Rheumatoid Arthritis (JRA)" ], "interventions": [ { "name": "Hydroxyurea", "type": "DRUG" }, { "name": "Alemtuzumab", "type": "DRUG" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Thiotepa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paul Szabolcs", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Months", "maximum_age": "55 Years", "sex": "ALL", "summary": "2 Months to 55 Years" }, "enrollment_count": 100, "start_date": "2014-02-04", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01962415" }, { "nct_id": "NCT06671054", "title": "A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis (RA)" ], "interventions": [ { "name": "AP1189, 40 mg", "type": "DRUG" }, { "name": "AP1189, 70 mg", "type": "DRUG" }, { "name": "AP1189, 100 mg", "type": "DRUG" }, { "name": "AP1189 matching placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SynAct Pharma Aps", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2024-10-01", "completion_date": "2025-12", "has_results": false, "last_update_posted_date": "2025-10-06", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 3, "location_summary": "Cutler Bay, Florida • Miami, Florida • Duncansville, Pennsylvania", "locations": [ { "city": "Cutler Bay", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Duncansville", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06671054" }, { "nct_id": "NCT02469662", "title": "Clinical Outcomes Study of the Nexel Total Elbow", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Elbow Joint Destruction", "Post-traumatic Lesions", "Ankylosed Joints", "Advanced Rheumatoid Arthritis", "Joint Instability or Loss of Motion", "Acute Comminuted Articular Fracture of Elbow Joint Surfaces", "Bone Loss Contributing to Elbow Instability", "Bilateral Ankylosis From Causes Other Than Active Sepsis", "Post-traumatic Arthritis", "Degenerative Arthritis" ], "interventions": [ { "name": "Nexel Total Elbow", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 134, "start_date": "2015-06", "completion_date": "2036-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-10-02T11:12:46.466Z", "location_count": 4, "location_summary": "Golden, Colorado • Charlotte, North Carolina • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Golden", "state": "Colorado" }, { "city": "Charlotte", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Germantown", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02469662" } ] }